2-[(2-aminoethyl)amino]-6-methylpyrimidin-4(3H)-one, 95.0%, 250mg

(S)-3-((tert-Butoxycarbonyl)amino)-3-(3-cyanophenyl)propanoic acid, 95.0%, 1g

EDC hydrochloride, 99.0%, 25g

5-((Methylamino)methyl)pyrrolidin-2-one, 95%, 250mg

2-{[5-(furan-2-yl)-1,3,4-oxadiazol-2-yl]sulfanyl}acetic acid, 97%, 10g

1,1'-Azobis(N,N-dimethylformamide), 95.0%, 100g

2-Amino-5,7-dimethyl-4,5,6,7-tetrahydro-1-benzothiophene-3-carbonitrile, 95%, 500mg

Bicyclo[2.2.2]octan-2-one, 95.0%, 5g

(2R,3R,4S,5R)-6,6-bis(ethylthio)hexane-1,2,3,4,5-pentaol, 98+%, 5g

2-(3-Ethoxy-5-fluorophenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 97%, 250mg

(R)-Ethyl 3-amino-2,5-dioxopyrrolidine-3-carboxylate, 97.0%, 1g

(S)-Homoserine-lactone hydrochloride, 97.0%, 10g

5'-Chloro-2'-hydroxy-4'-methylacetophenone>95.0%(GC)25g